Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

BioLife Solutions Inc

BLFS
Current price
26.24 USD +0.87 USD (+3.43%)
Last closed 25.18 USD
ISIN US09062W2044
Sector Healthcare
Industry Medical Instruments & Supplies
Exchange NASDAQ
Capitalization 1 264 978 944 USD
Yield for 12 month +103.89 %
1Y
3Y
5Y
10Y
15Y
BLFS
21.11.2021 - 28.11.2021

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington. Address: 3303 Monte Villa Parkway, Bothell, WA, United States, 98021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

29.8 USD

P/E ratio

Dividend Yield

Current Year

+143 271 000 USD

Last Year

+161 759 000 USD

Current Quarter

+30 571 000 USD

Last Quarter

+28 328 000 USD

Current Year

+46 752 000 USD

Last Year

+53 822 000 USD

Current Quarter

+21 806 000 USD

Last Quarter

+14 893 000 USD

Key Figures BLFS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -28 005 000 USD
Operating Margin TTM -5.1 %
PE Ratio
Return On Assets TTM -5.97 %
PEG Ratio 65.3833
Return On Equity TTM -15.04 %
Wall Street Target Price 29.8 USD
Revenue TTM 146 956 992 USD
Book Value 7.04 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 29.7 %
Dividend Yield
Gross Profit TTM 54 073 000 USD
Earnings per share -1.1 USD
Diluted Eps TTM -1.1 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY 640 %
Profit Margin -31.32 %

Dividend Analytics BLFS

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History BLFS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:14
Payout Ratio
Last Split Date 29.01.2014
Dividend Date

Stock Valuation BLFS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 250
Enterprise Value Revenue 8.6424
Price Sales TTM 8.6078
Enterprise Value EBITDA -36.0234
Price Book MRQ 3.8867

Financials BLFS

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators BLFS

For 52 weeks

12.45 USD 28.88 USD
50 Day MA 24.2 USD
Shares Short Prior Month 3 500 248
200 Day MA 21.5 USD
Short Ratio 6.39
Shares Short 2 683 541
Short Percent 8.55 %